Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.413ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.268ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.409ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.587ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.232ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.333ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ED.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used